Publications by authors named "Richard Edmondson"

Claim this Profile
F
Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer.
Melanie Seaton, Sarah Harbach, Joanne Oke, Thomas D J Walker, Jessica Dalton-O'Reilly, Richard J Edmondson

Clin Transl Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced epithelial ovarian cancer in older patients.
Victoria Cullimore, Kezia Gaitskell, Rebecca Newhouse, Kathryn Baxter, Nicholas Wood, Richard J Edmondson

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns and Goals of Women with Isolated Mesh-Associated Pain Syndrome Accessing a Quaternary Mesh Referral Service: A Thematic Analysis.
Hawra Badri, Lucy Dwyer, Claire Serridge, Kelechi Ajoku, Karen Ward, Richard Edmondson

Int Urogynecol J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of vaginal prolapse and stress incontinence mesh complications in a quaternary mesh complications service in the United Kingdom (U.K): a 5-year observational study.
Hawra Badri, Azita Rajai, Karen Ward, Richard Edmondson, Fiona Reid

BMC Womens Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a platform to investigate the heterogeneity of outcomes for patients with ovarian cancer.
Kathryn Baxter, J Booth, A Hawarden, N Wood, A Fisher, Richard Edmondson

BMJ Open Qual· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.
Robert D Morgan, Xin Wang, Bethany M Barnes, Laura Spurgeon, Aurore Carrot, Richard J Edmondson

Br J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise.
Kathryn Baxter, Heather Agnew, Jennie Morgan, Cathrine Holland, Darren Flynn, Richard Edmondson

J Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
Esther Moss, Alexandra Taylor, Adrian Andreou, Christine Ang, Rupali Arora, Richard Edmondson

Eur J Obstet Gynecol Reprod Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib.
Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O'Sullivan, Rachel L O'Donnell, Richard J Edmondson

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer.
Maryam Zanjirband, Nicola Curtin, Richard J Edmondson, John Lunec

Oncotarget· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering strategies to optimise adoptive cell therapy in ovarian cancer.
Catarina Guerra, Milena Kalaitsidou, Gray Kueberuwa, Robert Hawkins, Richard Edmondson

Cancer Treat Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer-Quality of Life Evaluation Research) Prospective, International, Multicentre Study.
Aarti Lakhiani, Carole Cummins, Satyam Kumar, Joanna Long, Vivek Arora, Richard Edmondson

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the likelihood of a pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer.
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Richard J Edmondson

J Clin Pathol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer.
Nicola Flaum, John Bowes, Miriam J Smith, Emma J Crosbie, Richard Edmondson

Genet Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.
Robert D Morgan, Andrew R Clamp, Daniel J White, Marcus Price, George J Burghel, Richard J Edmondson

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in and .
Sue Philpott, Maria Raikou, Ranjit Manchanda, Michelle Lockley, Naveena Singh, Richard Edmondson

J Med Genet· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome.
Thomas D J Walker, Zahra F Faraahi, Marcus J Price, Amy Hawarden, Caitlin A Waddell, Richard J Edmondson

Br J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer.
Amy Hawarden, Marcus Price, Bryn Russell, Godfrey Wilson, Laura Farrelly, Richard Edmondson

PLoS One· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer.
Sudha Sundar, Andy Nordin, Jo Morrison, Nick Wood, Sadaf Ghaem-Maghami, Richard Edmondson

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Reflex Germline Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Richard J Edmondson

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer.
Nicola Flaum, Emma J Crosbie, Richard Edmondson, Emma R Woodward, Fiona Lalloo

Genet Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two questionnaires to diagnose obstructive defecation syndrome during pregnancy and post-natally.
Joanne Sentance, Katie Stocking, Richard J Edmondson, Rohna Kearney

Int Urogynecol J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, Melanie E Powell, Richard J Edmondson

Mod Pathol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study.
Carole Cummins, Satyam Kumar, Joanna Long, Janos Balega, Tim Broadhead, Richard J Edmondson

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Robert D Morgan, George J Burghel, Nicola Flaum, Michael Bulman, Philip Smith, Richard J Edmondson

Br J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis